Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Lithera begins phase IIb trial of LIPO-202 for the reduction of subcutaneous fat

March 13, 2013

HanAll BioPharma patents new AMPK inhibitors

March 11, 2013

Korean researchers present clinical data for DP-R206 and ibandronate

March 11, 2013

First in-human pharmacokinetic study for DA-0831

March 11, 2013

Protalix gains approval to initiate study of oral treatment for Gaucher's disease in Israel

March 11, 2013

FDA advisory committee votes against salmon calcitonin use

March 11, 2013

Janssen files MAA for fixed-dose combination of canagliflozin and metformin

March 8, 2013

GSK files for European approval of albiglutide

March 8, 2013

Researchers at Two to Biotech divulge new peptides

March 8, 2013

Dr. Reddy's Laboratories presents new series of CETP inhibitors

March 8, 2013

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...